Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparing Methods to Assess Treatment Effect Heterogeneity in General Parametric Regression Models.

Statistics in medicine·2026
Same author

Overview and Practical Recommendations on Using Shapley Values for Identifying Predictive Biomarkers via CATE Modeling.

Statistics in medicine·2026
Same author

Using Individualized Treatment Effects to Assess Treatment Effect Heterogeneity.

Statistics in medicine·2025
Same author

WATCH: A Workflow to Assess Treatment Effect Heterogeneity in Drug Development for Clinical Trial Sponsors.

Pharmaceutical statistics·2024
Same author

A framework for longitudinal latent factor modelling of treatment response in clinical trials with applications to Psoriatic Arthritis and Rheumatoid Arthritis.

Journal of biomedical informatics·2024
Same author

All that Glitters Is not Gold: Type-I Error Controlled Variable Selection from Clinical Trial Data.

Clinical pharmacology and therapeutics·2024
Same journal

A Mixture of Distributed Lag Non-Linear Models to Account for Spatially Heterogeneous Exposure-Lag-Response Associations.

Statistics in medicine·2026
Same journal

Practical Considerations for Gaussian Process Modeling for Causal Inference in Quasi-Experimental Studies With Panel Data.

Statistics in medicine·2026
Same journal

Covariate Adjustment for Wilcoxon Two Sample Statistic and Test.

Statistics in medicine·2026
Same journal

Beyond Fixed Thresholds: Optimizing Summaries of Wearable Device Data via Piecewise Linearization of Quantile Functions.

Statistics in medicine·2026
Same journal

A Causal Framework for Evaluating the Total Effect of Strategies Aiming to Expand Screening and to Improve Outcomes.

Statistics in medicine·2026
Same journal

Causal Effects on Nonterminal Event Time With Application to Antibiotic Usage and Future Resistance.

Statistics in medicine·2026
See all related articles

Related Experiment Video

Updated: Jun 17, 2026

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.7K

Using knockoffs for controlled predictive biomarker identification.

Konstantinos Sechidis1, Matthias Kormaksson2, David Ohlssen2

  • 1Advanced Methodology and Data Science, Novartis Pharma AG, Basel, Switzerland.

Statistics in Medicine
|July 30, 2021
PubMed
Summary
This summary is machine-generated.

Identifying predictive variables is crucial for personalized medicine. This study introduces novel knockoff filters to accurately identify which baseline variables truly predict treatment response, improving patient subgroup identification.

Keywords:
false discovery rateheterogeneous treatment effectknockoff filterpredictive biomarker identification

More Related Videos

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

1.0K
Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
03:08

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Published on: October 3, 2025

491

Related Experiment Videos

Last Updated: Jun 17, 2026

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.7K
Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

1.0K
Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
03:08

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Published on: October 3, 2025

491

Area of Science:

  • Biostatistics
  • Translational Medicine
  • Machine Learning in Healthcare

Background:

  • Personalized medicine requires identifying patient subgroups who benefit from specific treatments.
  • Subgroup identification relies on pinpointing baseline variables (e.g., biomarkers) that predict treatment effects.
  • Current methods often provide variable importance scores but don't definitively confirm predictive value.

Purpose of the Study:

  • To address the challenge of identifying truly predictive variables for treatment effect.
  • To introduce a novel application of the knockoff framework for predictive variable selection.
  • To develop and validate new methods for subgroup identification in clinical settings.

Main Methods:

  • Utilized the knockoff framework, a method for controlling false discovery rates.
  • Developed a parametric knockoff filter based on penalized linear regression variable importance scores.
  • Developed a non-parametric knockoff filter leveraging causal forest variable importance scores.

Main Results:

  • The proposed knockoff filters effectively identify predictive variables, addressing limitations of existing importance scores.
  • Simulations demonstrated the robust performance of the novel methodologies.
  • The methods were successfully applied to data from a randomized clinical trial.

Conclusions:

  • The novel knockoff filters provide a statistically rigorous approach to predictive variable selection.
  • This methodology enhances the ability to identify patient subgroups for targeted therapies.
  • The findings have significant implications for advancing personalized medicine and clinical trial analysis.